Cargando…
Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database
OBJECTIVE: To understand, through an analysis of health insurance claims data, the current treatment status and medical cost of multiple sclerosis (MS) in Japan. METHODS: We analyzed claims data (January 2005–January 2016) from the Japan Medical Data Center Co., Ltd., identifying MS patients, except...
Autores principales: | Ogino, Mieko, Okamoto, Shuichi, Ohta, Hiroyuki, Sakamoto, Mariko, Nakamura, Yusuke, Iwasaki, Kosuke, Yoshida, Manami, Hiroi, Shinzo, Kawachi, Izumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724648/ https://www.ncbi.nlm.nih.gov/pubmed/29242717 http://dx.doi.org/10.1111/cen3.12411 |
Ejemplares similares
-
Current treatment status and medical cost for multiple sclerosis based on analysis of a Japanese claims database
por: Ogino, Mieko, et al.
Publicado: (2016) -
Neurological safety of fingolimod: An updated review
por: Yoshii, Fumihito, et al.
Publicado: (2017) -
Once‐daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing–remitting multiple sclerosis
por: Yamamura, Takashi, et al.
Publicado: (2017) -
Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims database
por: Kawachi, Izumi, et al.
Publicado: (2019) -
Diagnosis and treatment of influenza based on health insurance claims between the 2010–2011 and 2019–2020 influenza seasons in Japan
por: Shimizu, Eiko, et al.
Publicado: (2022)